A nurse is teaching the family of a child with ADHD about her diet and medications. The child is prescribed methylphenidate (Ritalin) every day. In teaching about the client's diet, it is most important that the nurse encourage the child to avoid which foods and/or drinks?

A. "You will need to take an anticonvulsant of some type for your lifetime."

This statement may be accurate for some individuals with chronic or recurrent seizure disorders, but it is a generalization. The duration of anticonvulsant therapy varies from person to person, and some individuals may eventually be able to discontinue medication under the guidance of their healthcare provider.

B. "This medication should be taken until you haven't had a seizure for a month."

While seizure control is a factor in determining the duration of treatment, setting a specific timeframe (e.g., one month) may not be applicable to everyone. The decision to continue or discontinue anticonvulsant therapy is usually individualized and based on various factors, including the type of seizure disorder and the individual's response to treatment.

C. "Seizures are unpredictable and so is the duration of the treatment."

This is the best response. It acknowledges the variability in seizure disorders and the individualized nature of treatment duration. Seizure management is often an ongoing process that requires monitoring and adjustments based on the person's specific circumstances.

D. "You will only need to take it for a short period of time because anticonvulsants will cure the seizure disorder."

Anticonvulsants are typically used to manage and control seizures rather than cure the underlying seizure disorder. While some individuals may experience a period of seizure freedom and be able to discontinue medication, this is not true for everyone. The duration of treatment varies, and some individuals may require long-term or even lifelong therapy.

A. Administer the dose since the patient is not toxic.

This is not the appropriate action. With a drowsy patient and a high serum phenytoin level, there is a concern for toxicity. Administering the next dose could worsen the toxicity.

B. Contact the provider to discuss decreasing the phenytoin dose.

While adjusting the dose may be a consideration, the immediate action should be to withhold the next dose and report the elevated level to the healthcare provider. The provider can then determine the appropriate course of action.

C. Give the drug and monitor closely for adverse effects.

Giving the drug without further intervention is not appropriate when there are signs of potential toxicity, such as drowsiness. Monitoring alone is not sufficient in this case.

D. Report drug toxicity to the providers.

This is the correct choice. With a drowsy patient and a serum phenytoin level of 18 mcg/mL, which is considered high, reporting the drug toxicity to the healthcare provider is the immediate and appropriate action. The provider can then determine the next steps, such as adjusting the dose or ordering additional tests.